Page 6 - Sciences Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Top Cannabis Stock Every Investor Should Consider Today More on: Image source: Getty Images Growth stocks are still in fashion today. And growth investors are increasingly looking to cannabis stocks right now in a bid for outsized returns. There are many reasons for this. However, the sheer growth that’s expected to result from legalization initiatives is astounding. Indeed, a recent report shared by Grand View Research, Inc. highlighted these prospects. The report stated that the global legal pot market size is expected to touch $84 billion by 2028. That’s not b...

Curaleaf Completes Acquisition of EMMAC and Secures US$130 Million Investment from a Single Strategic Institutional Investor News provided by Share this article Share this article EMMAC brings vertically integrated operations in Europe with a presence in key medical cannabis markets, including the UK, Germany, Italy, Spain, and Portugal Strategic investor to fund cash portion of acquisition and Curaleaf's growth initiatives in Europe WAKEFIELD, Mass., April 7, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provide...

Curaleaf Completes Acquisition of EMMAC and Secures US$130 Million Investment from a Single Strategic Institutional Investor Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis has successfully completed the previously announced acquisition of EMMAC Life Sciences Limited (“EMMAC”), the largest vertically integrated independent cannabis company in Europe, for base consideration of approximately US$50 million in cash and 17.5 million shares of Curaleaf, with additional c...

Curaleaf Completes EMMAC Acquisition, Sells Stake in New International Operation Chris Furnari - Apr 07, 2021 at 11:21 AM Curaleaf Holdings has completed its acquisition of Europe’s EMMAC Life Sciences and brought on a new minority partner in the process. In a news release, Curaleaf said it raised $130 million from an unnamed strategic institutional investor by selling a 31.5% equity stake in its newly established Curaleaf International Holdings business, which holds the EMMAC investment. According to Curaleaf, the equity sale will fund the $50 million cash component of the EMMAC purchase ...

Weed Giant Curaleaf Acquires London-Based Medical Marijuana Company EMMAC On Tuesday, March 9th, Curaleaf Holdings announced it had signed an ironclad agreement to acquire EMMAC Life Sciences Limited for nearly $286 million—85% to be paid in Curaleaf shares and 15% in cash.  The acquisition gives Curaleaf a defined lead against other U.S. operators in the European cannabis market. Curaleaf CEO Joseph Bayern commented that the agreement “marks a milestone moment as Curaleaf will immediately become the U.S. multi-state operator with the largest European footprint. Our acquisition of EMMAC ...